Genta-Aventis Case Study: Failing Strategies Within Late Stage Vertical Licensing
| Materialtyp: | Elektronisk Tidskrift |
|---|---|
| Språk: | engelska |
| Publicerad: |
MarketLine, a Progressive Digital Media business
|
| Länkar: | Full text available on EBSCOhost[Nov 2005-Nov 2005 |
Liknande verk
IDEC-Genentech Case Study: Successful Late Stage Licensing Strategies
Roche-Kosan Case Study: Successful Early Licensing Strategies
Forest Laboratories & Schering-Plough Case Studies: Pharmaceutical Licensing Strategies
Aventis SWOT Analysis
Sanofi-Aventis Case Study: Building a Successful Insulin Portfolio
Sanofi-Aventis SWOT Analysis
Licensing Loyalty
av: McLeod
av: McLeod
License to Play
av: Daliot-Bul
av: Daliot-Bul
License to Wed
av: Richman
av: Richman
Licensing Journal
Failing Families, Failing Science
av: Lincoln
av: Lincoln
Licensed Practical Nurse
Vertical Reefs
av: Wicksten
av: Wicksten
Lipitor Case Study: Lifecycle Management Strategies
Failed Frontiersmen
av: Donahue
av: Donahue
Words Fail
av: Dickinson
av: Dickinson
The Revolution that Failed
av: Fairclough
av: Fairclough
Failed Evidence
av: Harris
av: Harris
Failed Promises
av: Konisky
av: Konisky
IPO Exit Strategies Case Study: Undertaking a Successful IPO Exit Strategy
Staging Harmony
av: Brokaw
av: Brokaw
Staging Asia
av: Kuruppath
av: Kuruppath
Setting the Stage
av: Hays
av: Hays
Subversive Stages
av: Komporaly
av: Komporaly
Staging Revolution
av: Fan
av: Fan
Occupying the Stage
av: Bredeson
av: Bredeson
Staging Family
av: Mullenneaux
av: Mullenneaux
Staging the Amistad
av: Christensen
av: Christensen
On Stage Alone
av: Gitelman
av: Gitelman
Staging Ghana
av: Schauert
av: Schauert
Stage for Action
av: Dail
av: Dail
The Stages of Memory
av: Young
av: Young
Liknande verk
- IDEC-Genentech Case Study: Successful Late Stage Licensing Strategies
- Roche-Kosan Case Study: Successful Early Licensing Strategies
- Forest Laboratories & Schering-Plough Case Studies: Pharmaceutical Licensing Strategies
- Aventis SWOT Analysis
- Sanofi-Aventis Case Study: Building a Successful Insulin Portfolio